Talk to your OBGYN about it and follow the instructions you get.
As for the article about the Austrailan flu vaccine issue, it is not accurate and is misleading. Here are the facts:
M.
From the CDC:
What 2010-11 seasonal influenza (flu) vaccines will be available for children and adults in the United States?
There are two types of seasonal influenza vaccines for children and adults: the trivalent inactivated vaccine (TIV) (the flu shot) and the live attenuated vaccine (nasal spray)
The following vaccines will be available for children and adults this season:
Vaccine Trade name Manufacturer Age group
TIV Fluzone sanofi pasteur >6 mos
TIV Fluvirin Novartis Vaccine >4 yrs
TIV Agriflu Novartis Vaccine >18 yrs
TIV Fluarix GlaxosmithKline >3 yrs
TIV FluLaval ID Biomedical Corp. of Quebec, a subsidiary of GlaxoSmithKine >18 yrs
TIV Afluria* CSL Biotherapies >9 yrs
TIV High Dose Fluzone High Dose sanofi pasteur >65 yrs
LAIV FluMist MedImmune 2–49 yrs
*However, if no other age-appropriate, licensed inactivated seasonal influenza vaccine is available for a child aged 5 years through 8 years old who has a medical condition that increases their risk for influenza complications; providers may use Afluria. However, providers should discuss the benefits and risks of influenza vaccination with the parents or caregivers before administering Afluria.
A more detailed table is available on CDC’s website.
What was the experience in 2010 in the Southern Hemisphere when using flu vaccines made by CSL Biotherapies?
Australia and New Zealand are the only two Southern Hemisphere countries to use CSL Biotherapies seasonal flu vaccine during the 2010 flu season. During the 2010 flu season in Australia, administration of seasonal flu vaccine manufactured by CSL Biotherapies (brand names Fluvax and Fluvax Junior) was associated with increased frequency of fever and febrile seizures in children aged 6 months through 4 years old. In Australia, fever in children aged 5 through 8 years has also been reported following vaccination with Fluvax.
Extensive investigations by Australian authorities have indicated that administration of CSL flu vaccine in 2010 was associated with fevers and febrile seizures in young children in the 4-24 hours following vaccination at higher rates than was observed with seasonal flu vaccine during previous years in Australia. On April 23, 2010, seasonal flu vaccination of otherwise healthy children 5 years and younger was suspended in Australia by the Chief Medical Officer. Similarly, following reports of febrile seizures, the New Zealand Ministry of Health recommended against use of CSL Fluvax for children less than 5 years. In addition, there have been increased reports of fever in children aged 5 years through 8 years after Fluvax or Fluvax Jr in 2010 compared to the previous three flu seasons. To date, despite extensive investigations, no cause has been identified to explain these findings.
While data are limited, no increase in fever or febrile seizures has been reported to date among children administered other flu vaccines during the 2010 flu season in the Southern Hemisphere. On July 30, 2010, vaccination of children less than 5 years was allowed to resume in Australia using flu vaccines other than the CSL flu vaccines.
In several studies conducted in flu seasons prior to 2010-11 in the United States, no association between flu vaccine administration and febrile seizures has been detected. Afluria was approved for use in adults 18 years and older in 2007, and subsequently, approved for use in children age 6 months and older in November 2009. Thus Afluria has not been widely used for pediatric vaccination of U.S. children.
Are CSL flu vaccines licensed for use in the United States?
The seasonal CSL flu vaccine, marketed in the United States under the brand name Afluria, is approved by FDA for use in people aged 6 months and older in the United States. However, on July 30, 2010, information was added to the Warnings and Precautions section of the Afluria package insert to inform U.S. healthcare practitioners that administration of CSL’s 2010 Southern Hemisphere flu vaccine has been associated with an increased number of reports compared to previous years of fever and febrile seizures following influenza vaccination in children aged predominantly less than 5 years.
What does CDC's Advisory Committee on Immunization Practices (ACIP) recommend regarding use of Afluria?
ACIP recommends:
Afluria should not be used in children aged 6 months through 8 years.
Other age-appropriate, licensed seasonal influenza vaccine formulations should be used for prevention of influenza in children aged 6 months through 8 years.
If no other age-appropriate, licensed seasonal influenza vaccine is available for a child aged 5 years through 8 years old who has a medical condition that increases their risk for influenza complications, Afluria may be given, and providers should discuss the benefits and risks of influenza vaccination with the parents or caregivers before administering Afluria.
What are CDC and FDA doing about this situation?
For the 2010-11 flu season, CDC and FDA will conduct enhanced vaccine safety monitoring for flu vaccines to monitor for new or unexpected adverse events. CDC and FDA will closely monitor for seizures after flu vaccination using existing vaccine safety data systems, including the Vaccine Adverse Event Reporting System (VAERS) and the Vaccine Safety Datalink (VSD) Project. VAERS reports following 2010-11 flu vaccinations will be regularly reviewed with special attention to reports of febrile seizures in children aged less than 10 years. Medical personnel at CDC and FDA will routinely review submitted VAERS reports and obtain any needed additional clinical or other information for reports of febrile seizures or other serious adverse events following administration of 2010-11 seasonal flu vaccine. The VSD will be used for rapid ongoing analyses to monitor for serious adverse events following seasonal flu vaccine including seizures in young children. VSD is also available to evaluate possible associations suggested by VAERS or other sources as needed.
Investigations into the cause(s) of fever and febrile seizures following vaccination with CSL flu vaccines are ongoing. FDA and CDC are collaborating with Australia’s regulatory authority (Therapeutic Goods Administration), other international regulatory counterparts, and CSL to obtain additional information.
What is a febrile seizure?
"Febrile" means "relating to a fever." In some young children aged less than 5 years old, having a fever from any cause can bring on a seizure. During a febrile seizure, a child often has spasms or jerking movements—large or small—and may lose consciousness. Febrile seizures usually last only a minute or two, and do not cause any permanent neurological damage. They are most common with fevers reaching 102°F (38.9°C) or higher but can also occur at lower temperatures or when a fever is going back down.
What kinds of things can cause febrile seizures?
Febrile seizures can happen with any condition that causes a fever, including typical childhood illnesses like a cold, the flu, an ear infection, or roseola.
Is there an increased risk for febrile seizures after children receive a flu vaccine?
Several studies of children in the United States have shown no increased risk for febrile seizures following seasonal flu vaccines. One study included more than 45,000 children aged 6 months–23 months who received influenza vaccines during the years 1991–2003. Multiple systems are in place to monitor adverse events, including seizures, after seasonal flu vaccines. There is no indication that seasonal flu vaccines or the 2009 H1N1 flu vaccines used in the United States during the 2009-10 flu season were associated with an increased risk for febrile seizures. Febrile seizures can occur, however, when a child is sick with an influenza (flu) virus infection.
How serious is a febrile seizure?
Most children who have febrile seizures recover quickly and have no lasting effects. However, febrile seizures often result in a visit to an emergency room and can be very frightening for parents and caregivers.
About 1 in 3 children who have one febrile seizure will have at least one more febrile seizure. Most children (greater than 90%) who have a seizure will not develop epilepsy. Genetic predisposition and other factors, such as cerebral palsy, delayed development, or other neurological abnormalities, increase a child’s risk for developing epilepsy after a febrile seizure.
I'm a parent or care giver of a child under 9 years. How can I be certain that flu vaccines are safe?
There are other seasonal flu vaccines available for children under 9 years in the United States for the 2010-11 flu season. No seasonal flu vaccines other than the CSL TIV used in the Southern Hemisphere have been found to increase the risk of a febrile seizure. In addition, no increased risk of febrile seizures was found after vaccination with the 2009 H1N1 flu vaccine. Flu vaccines have a long track record for safety. Vaccines, as with any medicines, carry some risks. The main adverse event associated with the seasonal flu vaccine is soreness at the injection site. See the Vaccine Information Statement (VIS) for seasonal influenza vaccine [51 KB, 2 pg]. Parents should speak with their child’s healthcare provider about any concerns they have about flu vaccines for their children.